Posted: 1 December 2021
The 2021 BioMelbourne Network Annual General Meeting and Networking Event was held on Tuesday 30 November virtually via Zoom.
BioMelbourne Network bestows Honorary Life Membership awards on Members whose service has provided significant benefit to the Network.
At the 2021 AGM we honoured two outstanding Members whose commitment over many years has supported the Healthtech Industry and progressed BioMelbourne Network’s strategic objectives.
Andrew was a BioMelbourne Network Board Member from 2014 to 2018, acting as Chair from 2015.
He is the founder and Managing Director of Commercial Eyes Pty Ltd and has over 30 years’ experience in the medical technology and pharmaceutical industry. In 2014, Andrew received Medicines Australia’s Pat Clear Award, in recognition of the significant role he played in bringing medicines into the Australian market and his overall contribution to the Australian Pharmaceutical Industry.
Andrew is the President of ARCS and an Advisory Council member of the Master of Biotechnology, University of Melbourne. In addition to his industry roles, he has also chaired various advisory boards, including 11 years on the Board of the Melbourne City Mission.
During his time with BioMelbourne Network, Andrew has worked to expand the profile of the organisation and develop the board. BioMelbourne Network is hugely appreciative of Andrew’s contribution to the sector.
Alun was a BioMelbourne Network Board Member from 2010 to 2018.
He is the Principal Director, Accelerating Business Growth, at KPMG Australia. He has over 25 years’ experience in assisting companies to access government support for innovation, research and development, technology commercialisation and business expansion activities.
During his time on the BioMelbourne Network Board, Alun served on the Nomination, Remuneration & Human Resources Committee. He is a Member of the Women in Leadership Awards Judging Panel and initiated the Non-Executive Director Lunch Series in 2015.
BioMelbourne Network is hugely appreciative of Alun’s continued support for the organisation and the wider Healthtech Industry.
Lusia Guthrie is retiring from her roles as BioMelbourne Network Chair and as a member of our Board of Directors.
At the AGM, BioMelbourne Network thanked Lusia for her support in driving our organisational strategy, and her interest and passion for the everyday running of the Network.
Through her deep connection to the industry as well as her knowledge, insight and vision, Lusia has built trust within our membership and contributed significantly to the development of BioMelbourne Network.
BioMelbourne Network is pleased to announce the appointment of David Herd as Chair of the BioMelbourne Network Board of Directors at the 2021 Annual General Meeting on 30 November.
BioMelbourne Network is pleased to announce the re-election for a second term of Dr Elane Zelcer as Deputy Chair of the BioMelbourne Network Board of Directors at the 2021 Annual General Meeting on 30 November.